The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Life Technologies's revenues will increase 0.3% and EPS will contract 0.0%.
The average estimate for revenue is $952.1 million. On the bottom line, the average EPS estimate is $0.96.
Last quarter, Life Technologies booked revenue of $962.5 million. GAAP reported sales were 2.5% higher than the prior-year quarter's $939.1 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $1.07. GAAP EPS of $0.69 for Q1 were 4.2% lower than the prior-year quarter's $0.72 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 66.1%, 50 basis points worse than the prior-year quarter. Operating margin was 21.8%, 70 basis points worse than the prior-year quarter. Net margin was 12.6%, 150 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $3.87 billion. The average EPS estimate is $4.20.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 209 members out of 227 rating the stock outperform, and 18 members rating it underperform. Among 56 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 53 give Life Technologies a green thumbs-up, and three give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Life Technologies is hold, with an average price target of $63.83.
Looking for alternatives to Life Technologies? It takes more than great companies to build a fortune for the future. Learn the basic financial habits of millionaires next door and get focused stock ideas in our free report, "3 Stocks That Will Help You Retire Rich." Click here for instant access to this free report.
- Add Life Technologies to My Watchlist.